Genoplan

About

Genoplan democratizes healthcare using genomics and deep learning to advance precision medicine and empower informed health decisions.

New York,New York,United States
11 - 50

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $14M
Industries: Artificial Intelligence,Biotechnology,Genetics,Health Care,InsurTech,Life Science,Machine Learning,Predictive Analytics
Founded date: Jan 29, 2015
Number Of Employee: 11 - 50
Operating Status: Active
Legal Name: Genoplan Inc.

Genoplan's mission is to democratize healthcare by harnessing the power of population genomics and deep learning. The company is dedicated to making genomics widely accessible, offering tools and analytics that empower individuals to make informed health decisions. Ultimately, Genoplan aims to contribute to the advancement of precision medicine while helping people take control of their well-being.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$19.90M

Genoplan has raised a total of $19.90M in funding over 2 rounds. Their latest funding was raised on Nov 20, 2018 from a Series B round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Nov 20, 2018	Series B	$1M	3	—	—	Detail
Jun 29, 2018	Series B	$14M	3	—	—	Detail
Mar 14, 2016	Series A	$4.40M	4	—	—	Detail
Jul 3, 2015	Seed	$500K	2	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

—

9

Genoplan is funded by 9 investors. Dayli Partners and Green Cross are the most recent investors.

Investor Name	Lead Investor	Funding Round
Dayli Partners	—	Series B
Green Cross	—	Series B
PIA Investment Management	—	Series B
DAYLI Financial Group	—	Series B
Samsung Ventures	—	Series A
Softbank Ventures Asia	—	Series A
SparkLabs Accelerator	—	Series A
WONIK Investment Partners	—	Series A
CyberAgent	—	Seed